Header Logo

Connection

Yuki Kageyama to Ipilimumab

Back to Details
This is a "connection" page, showing publications Yuki Kageyama has written about Ipilimumab.
Yuki Kageyama
Connection Strength
0.206
Ipilimumab
  1. Clinical outcomes of nivolumab plus ipilimumab in patients with metastatic non-clear cell renal cell carcinoma: Real-world data from a Japanese multicenter retrospective study. Int J Urol. 2023 09; 30(9):714-721.
    View in: PubMed
    Score: 0.206
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.